Rep. James Comer (R-KY) (Graeme Sloan/Sipa USA/Sipa via AP Images)
March 2, 2023 03:45 PM EST
Pharma

House over­sight chair calls for in­ves­ti­ga­tion in­to PBM­s' tac­tics to in­crease drug costs

Katherine Lewin

News Reporter

In an­oth­er ef­fort to in­ves­ti­gate phar­ma mid­dle­men and their im­pact on health­care costs, House Over­sight Com­mit­tee Chair James Com­er (R-KY) is

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Ab­b­Vie fi­nal­ly en­ters obe­si­ty race with $350M up­front for Gubra’s amylin

Af­ter Phase 3 de­pres­sion set­back, Neumo­ra paus­es two tri­als to make changes, scraps an­oth­er

AD­Cs from a decade-old Sin­ga­pore biotech find new life with $187M

No­vo Nordisk signs $354M part­ner­ship with AI-guid­ed biotech for ‘risky’ new meta­bol­ic mech­a­nisms

Pro­tag­o­nist, Takeda's prof­it shar­ing deal un­der spot­light af­ter Phase 3 blood dis­or­der tri­al win

sponsored

The per­fect storm: Why every­thing is in place for 2025 to be the year of GxP AI

A service from the Financial Times